697998007: Eslicarbazepine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with cytochrome P450 inhibitor mechanism of action (substance)\Cytochrome P450 2C19 inhibitor\Eslicarbazepine

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Anticonvulsant\Eslicarbazepine

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Eslicarbazepine

\Organic compound\Organic nitrogen compound\Eslicarbazepine

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2968414018 Eslicarbazepine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2968415017 Eslicarbazepine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4843301000005115 eslicarbazepin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Eslicarbazepine	Is a	Anticonvulsant	true	Inferred relationship	Some
Eslicarbazepine	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Eslicarbazepine	Is a	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some
Eslicarbazepine	Is a	Organic nitrogen compound	true	Inferred relationship	Some
Eslicarbazepine	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Cytochrome P450 2C19 inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Eslicarbazepine acetate	Is a	False	Eslicarbazepine	Inferred relationship	Some
Product containing eslicarbazepine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Eslicarbazepine	Inferred relationship	Some	1
Product containing eslicarbazepine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Eslicarbazepine	Inferred relationship	Some	1
Product containing only eslicarbazepine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Eslicarbazepine	Inferred relationship	Some	1
Product containing only eslicarbazepine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Eslicarbazepine	Inferred relationship	Some	1
Eslicarbazepine acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Eslicarbazepine	Inferred relationship	Some

This concept is not in any reference sets